Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
100.30
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks
April 10, 2026
As the sun sets on the era of easy profits from elevated interest rates, the titans of Wall Street are preparing to unveil a new chapter in their growth stories. For the first time in three years, the...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
The Era of the Megadeal: Inside the $438 Billion Surge Reshaping Corporate America
April 09, 2026
The first quarter of 2026 has concluded with a historic roar, as global Mergers and Acquisitions (M&A) reached a staggering $438 billion in deal value. This surge, a 155% increase over the same period...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock
↗
April 01, 2026
Via
Chartmill
Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen
↗
March 25, 2026
Via
Chartmill
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
April 09, 2026
The global financial landscape underwent a seismic shift in the first quarter of 2026, as a "perfect storm" of stabilizing interest rates and technological urgency triggered a historic wave of mergers...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
This Pharma Dividend Has Been Raised Every Single Year for Over a Decade
↗
April 07, 2026
Spun off from a Dividend King in 2013, this pharmaceutical stock is a rising star among dividend growth stocks.
Via
The Motley Fool
Topics
Intellectual Property
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?
↗
April 07, 2026
In the world of investing, stability is a prized commodity. Few companies embody that stability better than Abbott Laboratories (NYSE: ABT), a diversified healthcare powerhouse and a member of the...
Via
MarketBeat
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
April 07, 2026
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a...
Via
Finterra
Topics
Artificial Intelligence
Retirement
World Trade
The Decacorn of Performance: Whoop Secures $10.1 Billion Valuation in Landmark Series G Led by TPG
April 06, 2026
In a move that cements the "human performance" category as a pillar of the future economy, Whoop has officially closed a massive $575 million Series G funding round, catapulting the wearable technology...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
April 06, 2026
ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval...
Via
MarketMinute
Topics
Artificial Intelligence
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
April 06, 2026
ST. LOUIS — April 6, 2026 — Stereotaxis (NYSE: STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias and other endovascular procedures, announced today that...
Via
MarketMinute
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
April 03, 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known...
Via
Finterra
Topics
Artificial Intelligence
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot
April 03, 2026
As of April 3, 2026, Medtronic plc (NYSE: MDT) stands at a critical inflection point in its 77-year history. Once viewed as a lumbering healthcare conglomerate burdened by its own scale, the...
Via
Finterra
Topics
Artificial Intelligence
Initial Public Offering
Product Recall
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
April 03, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t...
Via
StockStory
Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance
April 02, 2026
The first quarter of 2026 has officially marked the end of the deal-making drought, ushering in a lucrative "advisory windfall" for Wall Street’s elite investment banks. Driven by a surge in...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Best Healthcare Stocks to Buy Right Now for Long-Term Growth
↗
April 01, 2026
These "boring" businesses can slowly and consistently increase shareholders' wealth.
Via
The Motley Fool
The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance
April 01, 2026
The first quarter of 2026 has signaled a definitive end to the "deal drought" that plagued the previous three years, as American corporations embark on an unprecedented wave of consolidation. Driven by...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
April 01, 2026
As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a...
Via
Finterra
Topics
Economy
Lawsuit
Product Recall
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
April 01, 2026
As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of...
Via
Finterra
Topics
Artificial Intelligence
Economy
Initial Public Offering
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
March 31, 2026
Date: March 31, 2026 Introduction Boston Scientific Corporation (NYSE: BSX) finds itself at a critical crossroads this morning. After a year of record-breaking growth and the successful launch of its...
Via
Finterra
Topics
Lawsuit
Product Recall
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
↗
March 30, 2026
The Schwab U.S. Dividend Equity ETF is increasing its allocation to healthcare dividend stocks.
Via
The Motley Fool
Topics
ETFs
Stocks
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
March 24, 2026
As the first quarter of 2026 draws to a close, the global mergers and acquisitions (M&A) market has delivered a paradox that is reshaping the financial landscape. Preliminary data reveals that total...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
March 23, 2026
CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)...
Via
MarketMinute
Topics
Supply Chain
2 Defensive Healthcare Stocks to Buy Right Now
↗
March 22, 2026
These two stocks make fantastic long-term holdings.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
March 19, 2026
As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now
↗
March 19, 2026
Don't give up on this leading dividend payer yet.
Via
The Motley Fool
The Best Dividend Stocks to Buy and Hold Forever
↗
March 12, 2026
They are relatively safe wealth compounders.
Via
The Motley Fool
Topics
Intellectual Property
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
March 11, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
March 09, 2026
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Profitable Stocks on Our Watchlist and 1 We Avoid
March 09, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.